BIOCON
Back to Balance Sheet
|
BIOCON Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹4,102 Cr | ₹3,985 Cr | ₹2,588 Cr | ₹3,420 Cr | ₹2,254 Cr |
What is the latest Capital Work in Progress ratio of BIOCON ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹4,102 Cr |
| Mar2024 | ₹3,985 Cr |
| Mar2023 | ₹2,588 Cr |
| Mar2022 | ₹3,420 Cr |
| Mar2021 | ₹2,254 Cr |
How is Capital Work in Progress of BIOCON Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,102 Cr | 2.92 | |
| Mar2024 | ₹3,985 Cr | 54.02 | |
| Mar2023 | ₹2,588 Cr | -24.35 | |
| Mar2022 | ₹3,420 Cr | 51.78 | |
| Mar2021 | ₹2,254 Cr | - | |
Compare Capital Work in Progress of peers of BIOCON
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BIOCON | ₹58,490.2 Cr | -1.8% | -8.8% | 5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,647.0 Cr | 0.1% | -0.4% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹157,862.0 Cr | -1.1% | -7.1% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,846.0 Cr | 0.2% | -4.5% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,720.0 Cr | 0.2% | -4% | 6% | Stock Analytics | |
| CIPLA | ₹98,795.9 Cr | 0% | -9.1% | -18.5% | Stock Analytics | |
BIOCON Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BIOCON | -1.8% |
-8.8% |
5.9% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses